Medical and Scientific Advisors

Medical Advisor

John K. Fink, M.D.

Dr. Fink is the Director of the Neurogenetic Disorders Clinic at the University of Michigan, Ann Arbor. He’s also a Professor in the university’s Department of Neurology and is a Physician Scientist at the Geriatric Research Education and Clinical Center, Ann Arbor Veterans Affairs Medical Center. His research interests are analysis of inherited and degenerative disorders of the nervous system (including hereditary spastic paraplegia, primary lateral sclerosis, inherited movement disorders, schizophrenia) and regulation of neuronal development.

Dr. Fink received his M.D. from the Medical College of Ohio in Toledo. He did his residency training in neurology and genetics at the University of Virginia, Charlottesville. At the National Institutes of Health in Bethesda, Maryland, he did a post-doctoral fellowship in the Developmental and Metabolic Neurology and Medical Genetics departments.

Scientific Advisory Board

Martha A. Nance, Scientific Advisory Board Chairman
Park Nicollet Clinic, St. Louis Park, MN
Dr. Nance received her B.S. from Yale University and her M.D. from the Medical College of Virginia. She did her residency training in neurology at the St Paul Ramsey Medical and the University of Minnesota Hospital and Clinic. At the University of Minnesota, she did her post-doctoral fellowship in Medical Genetics.

Scientific Advisory Board Members

Craig Blackstone, M.D., Ph.D.
Chief, Cellular Neurology Unit, National Institutes Neurological Disorders and Stroke NINDS), National Institutes of Health (NIH), Bethesda, MD
Robert Bowser, Ph.D.
Director, Center for ALS Research, University of Pittsburgh, School of Medicine, Pittsburgh, PA
Pedro Gonzalez-Alegre, MD
Department of Neurology. University of Iowa Hospitals and Clinics. Iowa City, IA
Mark Gudesblatt, MD
South Shore Neurological Associates, Long Island, NY
Catherine Lomen-Hoerth, MD, PhD
ALS Center, University of California at San Francisco, San Francisco, CA
Evan Reid, Ph.D.
Senior Research Associate, Department of Medical Genetics, and Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK
Peter Todd, MD, PhD
Assistant Professor, Department of Neurology, University of Michigan, Ann Arbor, MI
Jacinda Sampson, M.D., Ph.D.
Department of Neurology, University of Utah, Salt Lake City, UT
Michael Swash, M.D. FRCP
Emeritus Professor of Neurology, St. Bartholomew’s and The Royal London, Queen Mary School of Medicine and Dentistry, Queen Mary University of London, London, UK
Susan Perlman, M.D.
Department of Neurology, Director, Ataxia and Neurogenetics Program, UCLA Medical Center, Los Angeles, CA
Shoji Tsuji, MD, Ph.D.
Professor and Chairman of Department of Neurology, Brain Research Institute, Niigata University, Professor and Chairman of Department of Neurology, Graduate School of Medicine, University of Tokyo, Japan

"Science has come a long way in the past several years in discovering the cellular processes that are affected by PLS and HSP. I look forward to the day that we have a cure."

Mark Weber, Esq., chairman of the SPF Research Grant Committee.

Latest Article

State of HSP Research:The Promise and the Reality by Allen Bernard

Learn More

Research Study Groups

Learn More

Submit a Proposal

Learn how to become the next SPF grant recipient working to find a cure.

Learn More

© Copyright 2014 Spastic Paraplegia Foundation, Inc. All Rights Reserved | All information is completely confidential. The Spastic Paraplegia Foundation will under no circumstances allow any vendors or associations access to your information. Thank you for your continued support.